"The Institute is a combination of clinical care and scientific research, with patients and their families at the center of these efforts. Recognized nationally and internationally for its cancer (especially pancreatic cancer), heart, bariatric and genetic research, the Institute has assembled a team of physicians, scientists and clinical experts to generate solutions to challenging diseases and disorders."

During the past decade, HonorHealth Research Institute conducted 96 clinical trials. In the 10-year time frame, 96 clinical trials started and 16 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 46 clinical trials started and 9 clinical trials were completed. i.e. 19.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "HonorHealth Research Institute" #1 sponsor was "HonorHealth Research Institute" with 15 trials, followed by "Genentech, Inc." with 11 trials sponsored, "Hoffmann-La Roche" with 7 trials sponsored, "Celgene" with 5 trials sponsored and "Agenus Inc." with 5 trials sponsored. Other sponsors include 58 different institutions and companies that sponsored additional 58 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "HonorHealth Research Institute" #1 collaborator was "Lustgarten Foundation" with 5 trials as a collaborator, "Merck Sharp & Dohme LLC" with 5 trials as a collaborator, "National Cancer Institute (NCI)" with 5 trials as a collaborator, "Stand Up To Cancer" with 5 trials as a collaborator and "Translational Genomics Research Institute" with 5 trials as a collaborator. Other collaborators include 44 different institutions and companies that were collaborators in the rest 40 trials.

According to Clinical.Site data, the most researched conditions in "HonorHealth Research Institute" are "Melanoma" (12 trials), "Pancreatic Cancer" (10 trials), "Solid Tumor" (8 trials), "Breast Cancer" (6 trials) and "Gastric Cancer" (6 trials). Many other conditions were trialed in "HonorHealth Research Institute" in a lesser frequency.

Most popular intervention types in "HonorHealth Research Institute" are "Drug" (87 trials), "Biological" (17 trials), "Device" (9 trials), "Other" (6 trials) and "Combination Product" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (9 trials), "Pembrolizumab" (8 trials), "Gemcitabine" (7 trials), "Placebo" (7 trials) and "Cisplatin" (6 trials). Other intervention names were less common.

The vast majority of trials in "HonorHealth Research Institute" are 100 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "HonorHealth Research Institute". undefined are not yet recruiting, 29 are recruiting, 21 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 36 completed trials in HonorHealth Research Institute, undefined suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in HonorHealth Research Institute, 59 "Phase 1" clinical trials were conducted, 40 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".

HonorHealth Research Institute has several departments that took part in Clinical trials: "Virginia G Piper Cancer Care-Del Camino" - 38 trials, "Arizona Arrhythmia Consultants" - 17 trials, "Arizona Breast Cancer Specialists-Scottsdale" - 14 trials, "HonorHealth Neurology" - 9 trials, "Virginia G Piper Cancer Care-Glendale" - 4 trials, "HonorHealth Heart Group Deer Valley" - 2 trials